Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women

被引:67
作者
Fawzi, W
Msamanga, G
Renjifo, B
Spiegelman, D
Urassa, E
Hashemi, L
Antelman, G
Essex, M
Hunter, D
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[5] Muhimbili Univ, Coll Hlth Sci, Dept Community Hlth, Dar Es Salaam, Tanzania
[6] Muhimbili Univ, Coll Hlth Sci, Dept Obstet & Gynecol, Dar Es Salaam, Tanzania
关键词
HIV infection; vertical transmission; fetal death; vitamin; pregnancy; birth weight; Tanzania;
D O I
10.1097/00002030-200106150-00011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To examine predictors of vertical transmission of HIV-1 in Dar-es-Salaam, Tanzania. Design: Observational design. Methods: Consenting HIV-1-infected pregnant women (n = 1078) were enrolled in a trial to examine the role of vitamin supplements. Intrauterine HIV-1 infection (HIV-positive at birth); intrapartum and early breastfeeding transmission (HIV-positive at 6 weeks among those uninfected at birth) were defined using the PCR. Results: Of 734 infants who had a specimen taken at birth, 62 were HIV positive [8.4%; 95% confidence interval (Cl),6.4-10.5%], whereas 59 infants were positive among 367 infants who were uninfected at birth and were retested at 6 weeks (16.1%; 95%Cl, 12.3-19.8%). In multivariate analyses, maternal CD4 cell count, viral load, and clinical stage were significant predictors of both definitions of transmission. Viral load of 50 000 copies/ml or more at delivery was associated with a 4.21-fold increase in risk of intrapartum and early breastfeeding transmission (95%Cl, 1.59-11.13; P = 0.004). Babies who were HIV negative at birth and born before 34 weeks of gestation were 2.19 times more likely to become infected during intrapartum and early breastfeeding periods compared with those born after 37 weeks (95%Cl, 1.19-4.04; P = 0.01). Gonorrhea at baseline was related to intrauterine transmission [multivariate risk ratio (RR), 5.50; 95%Cl, 2.04-14.81; P < 0.001] but not intrapartum and early breastfeeding transmission. Signs of lower genital infections at or after enrollment were also associated with transmission. Conclusions: Reducing prematurity, rate of HIV disease progression, and maternal viral load at or after delivery could help to reduce vertical transmission. Treatment of sexually transmitted infections at onset of prenatal care, about 20 weeks on average, was inadequate for prevention of transmission. Whether sustained clearance of lower genital tract infections result in reduced transmission remains to be determined. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:1157 / 1165
页数:9
相关论文
共 37 条
[1]  
ABRAMS EJ, 1995, PEDIATRICS, V96, P451
[2]  
[Anonymous], 1993, AIDS, V7, P711
[3]   Interleukin 2 treatment for HIV infection [J].
Blankson, J ;
Siliciano, RF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (02) :236-238
[4]   The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis [J].
Brocklehurst, P ;
French, R .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (08) :836-848
[5]   POWER-SYSTEM APPLICATIONS FOR PHASOR MEASUREMENT UNITS [J].
BURNETT, RO ;
BUTTS, MM ;
STERLINA, PS .
IEEE COMPUTER APPLICATIONS IN POWER, 1994, 7 (01) :8-13
[6]  
COLTON T, 1974, STAT MED, P174
[7]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[8]  
Coutsoudis A, 1997, J ACQ IMMUN DEF SYND, V15, P86
[9]   6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso:: a double-blind placebo-controlled multicentre trial [J].
Dabis, F ;
Msellati, P ;
Meda, N ;
Welffens-Ekra, C ;
You, B ;
Manigart, O ;
Leroy, V ;
Simonon, A ;
Cartoux, M ;
Combe, P ;
Ouangré, A ;
Ramon, R ;
Ky-Zerbo, O ;
Montcho, C ;
Salamon, R ;
Rouzioux, C ;
Van de Perre, P ;
Mandelbrot, L .
LANCET, 1999, 353 (9155) :786-792
[10]   Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission - Effect of maternal zidovudine treatment on viral load [J].
Dickover, RE ;
Garratty, EM ;
Herman, SA ;
Sim, MS ;
Plaeger, S ;
Boyer, PJ ;
Keller, M ;
Deveikis, A ;
Stiehm, ER ;
Bryson, YJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (08) :599-605